Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Recommendation of “Moderate Buy” by Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI) has earned a consensus rating of “Moderate Buy” from the eleven brokerages that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $92.80.

MMSI has been the subject of a number of research reports. Robert W. Baird set a $83.00 price objective on Merit Medical Systems in a report on Friday, May 1st. Barrington Research dropped their target price on shares of Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating on the stock in a report on Monday, April 20th. Wells Fargo & Company reduced their target price on shares of Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Canaccord Genuity Group decreased their price target on shares of Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Finally, Wall Street Zen cut shares of Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Sunday, April 5th.

Insider Buying and Selling

In related news, insider Brian G. Lloyd purchased 2,000 shares of the company’s stock in a transaction dated Thursday, May 7th. The shares were purchased at an average cost of $62.62 per share, with a total value of $125,240.00. Following the transaction, the insider directly owned 2,000 shares in the company, valued at $125,240. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Lynne N. Ward sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $62.61, for a total value of $313,050.00. Following the completion of the sale, the director owned 7,809 shares in the company, valued at $488,921.49. The trade was a 39.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Gradient Investments LLC bought a new stake in Merit Medical Systems in the second quarter worth $1,657,000. GAMMA Investing LLC raised its position in shares of Merit Medical Systems by 235.4% in the 2nd quarter. GAMMA Investing LLC now owns 3,250 shares of the medical instruments supplier’s stock worth $225,000 after purchasing an additional 2,281 shares during the last quarter. Harbor Investment Advisory LLC purchased a new position in shares of Merit Medical Systems in the 2nd quarter worth about $50,000. Central Pacific Bank Trust Division boosted its stake in Merit Medical Systems by 13.9% in the 2nd quarter. Central Pacific Bank Trust Division now owns 3,107 shares of the medical instruments supplier’s stock worth $215,000 after purchasing an additional 380 shares in the last quarter. Finally, Epiq Partners LLC bought a new position in Merit Medical Systems in the 2nd quarter worth about $208,000. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Stock Up 1.6%

MMSI stock opened at $75.17 on Tuesday. Merit Medical Systems has a fifty-two week low of $59.74 and a fifty-two week high of $94.75. The business’s 50 day moving average price is $67.26 and its two-hundred day moving average price is $72.42. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08. The company has a market capitalization of $4.48 billion, a price-to-earnings ratio of 32.54, a price-to-earnings-growth ratio of 2.30 and a beta of 0.52.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The company had revenue of $381.88 million during the quarter, compared to analysts’ expectations of $377.59 million. During the same quarter last year, the business posted $0.86 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, analysts forecast that Merit Medical Systems will post 3.62 earnings per share for the current fiscal year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.